Cathie Wood acquired 5.26 Million Twist Bioscience shares worth $216 Million. That's 1.29% of their equity portfolio (23rd largest holding). The investor owns 10.08% of the outstanding Twist Bioscience stock. The first Twist Bioscience trade was made in Q4 2019. Since then Cathie Wood bought shares six more times and sold shares on three occasions. The investor's estimated purchase price is $388 Million, resulting in a loss of 44%.